GB1440214A - Vaccines in solid particulate form - Google Patents
Vaccines in solid particulate formInfo
- Publication number
- GB1440214A GB1440214A GB4181273A GB4181273A GB1440214A GB 1440214 A GB1440214 A GB 1440214A GB 4181273 A GB4181273 A GB 4181273A GB 4181273 A GB4181273 A GB 4181273A GB 1440214 A GB1440214 A GB 1440214A
- Authority
- GB
- United Kingdom
- Prior art keywords
- animal
- particles
- particulate form
- solid particulate
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
- A61K39/225—Porcine transmissible gastroenteritis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
1440214 Vaccines in solid particulate form UNIVERSITY OF ILLINOIS FOUNDATION 5 Sept 1973 41812/73 Heading A5B Pharmaceutical preparations for oral administration to animals comprise a villiarly effective attenuated virus vaccine e.g. transmissible gastroenteritis (TGE) vaccine in solid particulate form, the vaccine being subject to degradation by contact with the gastric secretions off the animal, and an enteric coating e.g. cellulose acetate phthalate, covering each particle, the particles having a maximum diameter of 2.0 mm such that they will pass from the stomach through the pyloric valve into the intestine of the animal before the enteric coating is destroyed by the gastric secretions. The particles are preferably spherical or approximately spherical and may additionally comprise a solid physiologically acceptable carrier e.g. an animal feedstuff. The particles may be encapsulated in a material which dissolves rapidly in the stomach of the animal e.g. gelatin.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US00285036A US3823228A (en) | 1971-09-29 | 1972-08-30 | Tge virus vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1440214A true GB1440214A (en) | 1976-06-23 |
Family
ID=23092469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4181273A Expired GB1440214A (en) | 1972-08-30 | 1973-09-05 | Vaccines in solid particulate form |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS535371B2 (en) |
AR (1) | AR197158A1 (en) |
AU (1) | AU5949773A (en) |
CA (1) | CA1023266A (en) |
DE (1) | DE2343570A1 (en) |
FR (1) | FR2197576B1 (en) |
GB (1) | GB1440214A (en) |
NL (1) | NL7312032A (en) |
PH (1) | PH10296A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0009577A1 (en) * | 1978-08-18 | 1980-04-16 | Burns-Biotec Laboratories Inc. | An oral vaccine preparation and a method for increasing the resistance of swine to swine-dysentery infection |
WO1999013869A1 (en) * | 1997-09-12 | 1999-03-25 | Gerold Lukowski | Humidity-proof and gastric juice-resistant medications for animals |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS584561Y2 (en) * | 1980-11-26 | 1983-01-26 | 日本濾過器株式会社 | bubble separator |
DK150008C (en) * | 1981-11-20 | 1987-05-25 | Benzon As Alfred | PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL ORAL POLYDEPOT PREPARATION |
US6024983A (en) * | 1986-10-24 | 2000-02-15 | Southern Research Institute | Composition for delivering bioactive agents for immune response and its preparation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3458621A (en) * | 1966-08-31 | 1969-07-29 | American Home Prod | Tablet dosage-form for the immunization of the intestinal tract with live virus preparations |
US3519710A (en) * | 1967-08-10 | 1970-07-07 | Edmund P Bass | Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth |
-
1973
- 1973-08-22 AU AU59497/73A patent/AU5949773A/en not_active Expired
- 1973-08-27 CA CA179,663A patent/CA1023266A/en not_active Expired
- 1973-08-29 DE DE19732343570 patent/DE2343570A1/en active Pending
- 1973-08-29 AR AR249824A patent/AR197158A1/en active
- 1973-08-30 FR FR7331447A patent/FR2197576B1/fr not_active Expired
- 1973-08-30 PH PH14977A patent/PH10296A/en unknown
- 1973-08-30 JP JP9679673A patent/JPS535371B2/ja not_active Expired
- 1973-08-31 NL NL7312032A patent/NL7312032A/en unknown
- 1973-09-05 GB GB4181273A patent/GB1440214A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0009577A1 (en) * | 1978-08-18 | 1980-04-16 | Burns-Biotec Laboratories Inc. | An oral vaccine preparation and a method for increasing the resistance of swine to swine-dysentery infection |
WO1999013869A1 (en) * | 1997-09-12 | 1999-03-25 | Gerold Lukowski | Humidity-proof and gastric juice-resistant medications for animals |
Also Published As
Publication number | Publication date |
---|---|
FR2197576B1 (en) | 1976-09-03 |
CA1023266A (en) | 1977-12-27 |
FR2197576A1 (en) | 1974-03-29 |
JPS535371B2 (en) | 1978-02-27 |
JPS4962618A (en) | 1974-06-18 |
AR197158A1 (en) | 1974-03-15 |
DE2343570A1 (en) | 1974-03-14 |
AU5949773A (en) | 1975-02-27 |
PH10296A (en) | 1976-11-10 |
NL7312032A (en) | 1975-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bechgaard et al. | Controlled-release multiple-units and single-unit doses a literature review | |
JP6081374B2 (en) | Protection of microbial cells from acid degradation | |
JP4718116B2 (en) | Microparticulate oral galenical dosage form for delayed and controlled release of pharmaceutically active ingredients | |
US7935334B2 (en) | Probiotics as alternative medicines against infectious diseases | |
JP4463109B2 (en) | Dietary supplement and aquatic animal feeding method | |
EP1037614B1 (en) | A double capsule for the administration of active principles in multiple therapies | |
ATE62130T1 (en) | PHARMACEUTICAL DEVICE IN THE FORM OF PELLETS WITH CONTINUOUS, DELAYED-RELEASE OF THE ACTIVE SUBSTANCE. | |
KR890009376A (en) | Spray dried ibuprofen | |
DE69322077D1 (en) | ORAL PHARMACEUTICAL FORMS BASED ON HYDROXYETHYL CELLULOSE WITH DELAYED DELIVERY OF ACTIVE SUBSTANCES | |
US5871751A (en) | Renibacterium salmoninarum vaccine and method for its preparation | |
BE818628A (en) | GELATIN CAPSULES RESISTANT TO GASTRIC SUCK AND THEIR PREPARATION | |
US3823228A (en) | Tge virus vaccine | |
US10806698B2 (en) | Composition for oral delivery of bioactive agents | |
JPS60501955A (en) | Composition | |
NZ275837A (en) | Coated oral dosage form: porous water-soluble core with hydrophobic coating | |
CA2534368A1 (en) | Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration | |
GB1440214A (en) | Vaccines in solid particulate form | |
US3119738A (en) | Medication for ruminants | |
GB630439A (en) | Improvements in or relating to pharmaceutical preparations | |
ES406781A1 (en) | Pharmaceutical compositions | |
US3488417A (en) | Veterinary preparations having a coating resistant to the rumen contents | |
DE69906964T2 (en) | DIAGANOSTIC METHOD AND DIAGNOSTIC MEANS USED TO EXECUTE SUCH METHOD | |
GB1436714A (en) | Medicinal process | |
ES476566A3 (en) | Procedure for the manufacture of biologically active components protected or encapsulated for feeding ruminants. (Machine-translation by Google Translate, not legally binding) | |
TWM617261U (en) | Capsules with crop stem and leaf extract particles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PLNP | Patent lapsed through nonpayment of renewal fees |